2008 annual financial data
Halozyme Therapeutics 2008 Operating margin
Direct answer
Operating margin was -575.47%.
Operating income was -50,434,702 USD and net income was -48,654,199 USD.
Operating cash flow was -35,373,864 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,764,139 USD
- Operating income
- -50,434,702 USD
- Net income
- -48,654,199 USD
- Operating cash flow
- -35,373,864 USD